Underutilization of therapy for hepatocellular carcinoma in the medicare population (Q34143512)

31 July 2017

title

Underutilization of therapy for hepatocellular carcinoma in the medicare population (English)

1 reference

31 July 2017

main subject

hepatocellular carcinoma

1 reference

Shimul A Shah

1

1 reference

31 July 2017

Jillian K Smith

2

1 reference

31 July 2017

Youfu Li

3

1 reference

31 July 2017

Sing Chau Ng

4

1 reference

31 July 2017

James E Carroll

5

1 reference

31 July 2017

Jennifer F Tseng

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

13 October 2010

1 reference

31 July 2017

1 reference

31 July 2017

volume

117

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

1019-1026

1 reference

Estimating the world cancer burden: Globocan 2000.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Development of a comorbidity index using physician claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Geographic variation within the United States in the incidence of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

New aspects of diagnosis and therapy of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

The burden of illness associated with hepatocellular carcinoma in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Non-surgical therapies of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Utilization of screening for hepatocellular carcinoma in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Hepatitis B virus and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

Rising incidence of hepatocellular carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

7 January 2021

An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

7 January 2021

Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

7 January 2021

Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

7 January 2021

Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

7 January 2021

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

7 January 2021

Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

7 January 2021

Epidemiology of hepatocellular carcinoma in USA

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25683

7 January 2021

Identifiers

DOI

10.1002/CNCR.25683

1 reference

31 July 2017

1 reference